The U.S. Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants used to ...

The U.S. Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants to treat ...

Researchers reviewing nearly 300 top-tier ADHD drug trials found that half skipped the rigorous, expert-led evaluations needed to rule out other conditions like depression or schizophrenia. With ...

Children younger than 6 years of age who are prescribed extended-release stimulants for attention-deficit hyperactivity disorder (ADHD) may experience ...

The FDA now requires updated labeling for all extended-release stimulant medications used to treat attention deficit hyperactivity disorder, warning of increased risk of weight loss and other side ...

Fennel Hoppe assesses clients for ADHD and autism. Hoppe says sometimes it can be hard to notice whether someone has ADHD.

Telehealth prescribing of stimulants for teens and adults with ADHD is not linked to a higher risk for substance use disorder vs in-person prescribing, a new study shows.

A major Swedish study of 247,420 individuals with attention-deficit/hyperactivity disorder (ADHD) has found that medication ...

People with ADHD often struggle with executive function, which Didier describes as “your brain’s GPS” for navigating your day ...

ADHD Advisor examines why ADHD often goes undiagnosed in women and girls, and how gender biases in symptoms and diagnosis ...

Actress and talk show host Busy Philipps as well as sports reporter Jay Glazer have both headed up separate campaigns for Qelbree, a non-stimulant ADHD treatment manufactured by Supernus. This marks a ...